USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
14 Sep 2022 | 02:45 PM GMT

Sustainable Business Models for Digital Health in Neurology

Anchored by:

Ciara Clancy
Chief Executive Officer
BEATS MEDICAL LTD

Participants:

Ciara Clancy Chief Executive OfficerBeats Medical Ltd
Ciara Clancy
Chief Executive OfficerBeats Medical Ltd
Jo Peddhinti AdvisoryHLTH Community
Jo Peddhinti
AdvisoryHLTH Community
Ashley Pippin DirectorNovartis
Ashley Pippin
DirectorNovartis
Ekta Foster-Lachmandas Digital Health Business CreationRoche Diagnostics
Ekta Foster-Lachmandas
Digital Health Business CreationRoche Diagnostics
Gaurav Shah Director - Business Development TransactionsBristol-Myers Squibb
Gaurav Shah
Director - Business Development TransactionsBristol-Myers Squibb
Kevin Donnelly Chief Executive OfficerPersonaDx
Kevin Donnelly
Chief Executive OfficerPersonaDx
Laetitia Delolme Director, Compliance & Digital TransformationIntegra LifeSciences
Laetitia Delolme
Director, Compliance & Digital TransformationIntegra LifeSciences
Maxime Champain Search & Evaluation lead, External InnovationBiogen
Maxime Champain
Search & Evaluation lead, External InnovationBiogen
Nina Bufi Lead, BDH Ventures, Digital Therapeutics EUBiogen
Nina Bufi
Lead, BDH Ventures, Digital Therapeutics EUBiogen
Ricardo C. Berrios Co-Founder & CEOAdhera Health, Inc.
Ricardo C. Berrios
Co-Founder & CEOAdhera Health, Inc.

About this Meeting

Digital health companies can take different routes to market, however, finding the one that is sustainable and scalable in the long term, is not an easy task. Are you on the search for the most sustainable business model for a digital health solution in neurology? Then this meeting is for you! 

While investments in digital health in neurology have increased in recent years, there is no true one-route to market and the right approach seems to combine more than one path. Finding the right commercialisation model to scale can be challenging, but the HealthXL community is here to help. This meeting will look at the most scalable and sustainable business models for digital health in neurology. Join this meeting to discuss: 

  • The four most popular routes to market: pharma, direct to consumer (D2C), payers, and employers. What can each route provide to the digital health company and what do they lack? How have previous partnerships succeeded or failed? 
  • What factors determine the best routes to market for a digital health product in neurology (e.g. type of product, the disease, patient profile, geography, etc)?  
  • Pricing strategies. Due to the nature of neurology, products are typically more personalized, leading to higher costs. How can digital health companies price their products to maximize adoption and revenue? What is the best pricing strategy for digital health companies with blended routes to market (e.g. D2C and partnerships with employers)? 
  • Adoption by both patients and physicians is critical for long-term partnership success. How does user experience affect adoption by patients? How can we educate physicians and integrate our product into their workflow?